Related Experiment Video
Updated: Jun 27, 2025
11:01
Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
13.6K
[EEG changes in patients with Alzheimer's disease]
S G Burd1,2,3, A V Lebedeva1,2, Yu V Rubleva1
1Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.
Summary
Alzheimer's disease (AD) diagnosis is improving with electroencephalogram (EEG) screening. Early detection of cognitive impairment through EEG changes can enhance patient prognosis.
Area of Science:
- Neurology
- Neuroscience
- Medical Diagnostics
Background:
- Cognitive impairment and dementia prevalence are rising globally.
- Alzheimer's disease (AD) is the primary cause of dementia, with significant projected increases in cases.
- Early identification of AD's pathophysiological changes is crucial for improving patient outcomes.
Purpose of the Study:
- To present observed electroencephalogram (EEG) changes in patients diagnosed with Alzheimer's disease (AD).
- To explore the potential of using EEG as a viable screening tool for individuals experiencing cognitive impairment.
Main Methods:
- Analysis of electroencephalogram (EEG) data from patients with Alzheimer's disease (AD).
- Review of existing literature on EEG patterns associated with cognitive decline and AD.
Main Results:
- Specific EEG alterations were identified in patients with Alzheimer's disease (AD).
- These EEG changes show potential for differentiating individuals with cognitive impairment.
Conclusions:
- Electroencephalogram (EEG) may serve as an effective screening method for early detection of Alzheimer's disease (AD).
- Utilizing EEG for screening can aid in the timely diagnosis and management of cognitive impairment.
Related Concept Videos
01:26Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
01:23Brain Waves
1.3K
Brain waves are electrical signals generated by the neurons in the brain, which are regularly monitored to measure mental activities. Brain waves and their frequency ranges can be measured using an electroencephalogram or EEG. There are four main types of brain waves, each with distinct characteristics:
1.3K
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183